Dr. Gore is one of the foremost inventors (currently in Small Molecule Hemophilia development) in the US with unique mastery in taking early stage PoC programs to commercialization at fraction of costs and multiples of speed. Proven technology visionary with ~21+ years of very broad and deep experience in R&D technical and program management from inception to commercialization, with >$1B/yr revenue programs; and 61 granted US and 271 world-wide patents.
Today, Dr. Makarand P. Gore is a natural products chemist with extensive experience in developing medicines from active plant extracts. He has launched five products approved for human use in India. Prior to dedicating his full focus to YewSavin, Dr. Gore worked for Antivirals (now Sarepta) where he developed the foundation for Morpholino based antiviral agents. He also worked at Hewlett Packard, leading a variety of development projects in digital printing, inkjet inks, pigment formulations, light-material interactions, and energy storage devices using hydrogen technologies. At YewSavin, Dr. Gore has gained extensive experience in developing small molecule therapeutics from bench to clinic with expertise in pharmacology, formulation and delivery science, and small molecule specific regulatory requirements. His contributions to the development and commercial launch of products across multiple fields have generated over $B/y revenue.
Over the course of his industrial research career, Dr. Gore has authored 61 US and 287 global granted patents, and received Eleven annual STAR Awards (given only to top 1% performers) at Hewlett Packard for his record of sustained innovation and direct impact on commercial success.
American Chemical Society, Member
Life Fellow of The Indian Chemical Society
Eleven annual Hewlett Packard STAR Awards
Fifty-Nine Patent Hewlett Packard Incentive Awards for successful issuance of patents
Hewlett Packard New Business Creation and Original Rugged and Durable Innovation Ware Award
CTO on 11+ projects including
* Hemophilia Blood Clotting Disorder past human Ex-vivo studies
* Emergency non-compressible wound treatment past POC animal studies
*Ultrahigh density >1000 KM solid state H2
* Development of antisense DNA/RNA analogs
* Inkjet Technologies for pigment based inks
* Natural products therapy for HIV/HCV treatments
* Novel optical media coating technology for direct labeling LightScribe
* SilverLock metallized and conductive printing with Jettable MOVCD and photochemistry
* Textile printing Inks program
* Blue-ray optical disc coatings program
With a focus on Innovation and Investment, the Powerful Group responds to the growing demand for a platform that champions ROI-based collaboration and empowerment to Entrepreneurs.
All rights reserved with the Step2StepUp Inc. & Pakute Marketing Pvt. Ltd. | Privacy Policy
